Cargando…

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

BAKGROUND: The EVI1(ecotropic virus integration site 1) gene codes for a zinc-finger transcription factor, whose transcriptional activation leads to a particularly aggressive form of acute myeloid leukaemia (AML). Although, EVI1 interactions with key proteins in hematopoiesis have been previously de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Benito, M, Conchillo, A, García, M A, Vázquez, I, Maicas, M, Vicente, C, Cristobal, I, Marcotegui, N, García-Ortí, L, Bandrés, E, Calasanz, M J, Alonso, M M, Odero, M D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967053/ https://www.ncbi.nlm.nih.gov/pubmed/20842122 http://dx.doi.org/10.1038/sj.bjc.6605874

Ejemplares similares

Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia
por: García-Ortí, Laura, et al.
Publicado: (2012)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
por: Hou, H-A, et al.
Publicado: (2011)

Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome
por: Bojesen, S E, et al.
Publicado: (2006)

New germline mutations in the hypervariable minisatellite CEB1 in the parents of children with leukaemia
por: Davies, B G, et al.
Publicado: (2007)

Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia
por: Lu, Y, et al.
Publicado: (2014)

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study
por: Iqbal, Javaid, et al.
Publicado: (2016)

Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
por: Mueller, B U, et al.
Publicado: (2006)

EVI1 dysregulation: impact on biology and therapy of myeloid malignancies
por: Birdwell, Christine, et al.
Publicado: (2021)

Implication of replicative stress-related stem cell ageing in radiation-induced murine leukaemia
por: Ban, N, et al.
Publicado: (2009)

Virome characterisation from Guthrie cards in children who later developed acute lymphoblastic leukaemia
por: Bogdanovic, G, et al.
Publicado: (2016)

Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients
por: Osman, Emad-Aldin I., et al.
Publicado: (2010)

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
por: Forero-Castro, Maribel, et al.
Publicado: (2017)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
por: Kamieniak, M M, et al.
Publicado: (2013)

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age
por: Stevens, A, et al.
Publicado: (2014)

Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications
por: Hultdin, M, et al.
Publicado: (2003)

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis
por: Fernández-Ramires, R, et al.
Publicado: (2009)

“EviMass”: A Literature Evidence-Based Miner for Human Microbial Associations
por: Srivastava, Divyanshu, et al.
Publicado: (2019)

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
por: Dono, M, et al.
Publicado: (2014)

High EVI1 Expression due to NRIP1/EVI1 Fusion in Therapy-related Acute Myeloid Leukemia: Description of the First Pediatric Case
por: D’Angiò, Mariella, et al.
Publicado: (2020)

Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia
por: Glass, Carolyn, et al.
Publicado: (2013)

Transcriptomal profiling of the cellular response to DNA damage mediated by Slug (Snai2)
por: Pérez-Caro, M, et al.
Publicado: (2008)

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer
por: Watters, A D, et al.
Publicado: (2002)

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays
por: Bièche, I, et al.
Publicado: (2002)

LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk
por: Tajuddin, S M, et al.
Publicado: (2014)

Corrigendum: “EviMass”: A Literature Evidence-Based Miner for Human Microbial Associations
por: Srivastava, Divyanshu, et al.
Publicado: (2020)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Sato, T, et al.
Publicado: (2014)

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours
por: Tanic, M, et al.
Publicado: (2013)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
por: Osorio, A, et al.
Publicado: (2011)

TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis
por: Davidsen, M L, et al.
Publicado: (2006)

Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells
por: Pepper, C, et al.
Publicado: (2007)

A prospective study of neurofibromatosis type 1 cancer incidence in the UK
por: Walker, L, et al.
Publicado: (2006)

Quantitative relationship between functionally active telomerase and major telomerase components (hTERT and hTR) in acute leukaemia cells
por: Ohyashiki, J H, et al.
Publicado: (2005)

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers
por: Kadouri, L, et al.
Publicado: (2008)

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer
por: Christoph, F, et al.
Publicado: (2006)

Mutation analysis of three genes encoding novel LKB1-interacting proteins, BRG1, STRADα, and MO25α, in Peutz–Jeghers syndrome
por: Alhopuro, P, et al.
Publicado: (2005)

Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
por: Souglakos, J, et al.
Publicado: (2008)

A moonlighting function of a chitin polysaccharide monooxygenase, CWR-1, in Neurospora crassa allorecognition
por: Detomasi, Tyler C, et al.
Publicado: (2022)

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression
por: Koppert, L B, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_1d7513b1675ukcvp4aa400uvsj